HELIXOR M Ampoules 0.1 mg, 8 pcs

Instructions for use for HELIXOR M Ampoules 0.1 mg, 8 pcs

Directions for use of the article Helixor M 0.1 mg: Helixor® A/-M/-P solution for injection is made from fresh mistletoe herb. It is used for the treatment of tumour diseases in accordance with the anthroposophical understanding of man and nature. It can be used for malignant tumour diseases, benign tumour diseases, prevention of relapses after tumour operations and defined precancerous conditions. It should be used as directed. Before use, it should be noted that Helixor® should not be used if one is hypersensitive to mistletoe preparations or suffers from acute inflammatory or high febrile diseases. Helixor® should also not be used in certain diseases such as chronic granulomatous diseases, autoimmune diseases and hyperthyroidism. Special caution is required when using it if you are hypersensitive to other substances or have primary brain and spinal cord tumours or intracranial metastases. The use of Helixor® together with other immunoactive medicinal products should only be carried out under medical consultation. Use during pregnancy and lactation requires caution. Helixor® is injected subcutaneously and the dose should be adjusted individually. Various reactions may occur, singly or in combination, and the increase in dose may be interrupted if adverse reactions occur. The duration of treatment is determined by the doctor and may be several years. In case of overdose, excessive inflammatory reactions may occur and in this case medical attention should be sought. The forgotten application should be made up as soon as possible. Possible side effects include a slight increase in body temperature, localised inflammatory reactions around the injection site and temporary mild swelling of regional lymph nodes. Allergic or allergy-like reactions may occur and require discontinuation of the preparation and medical treatment. Inflammatory irritation of the injection site may also occur. The occurrence of chronic granulomatous inflammation and autoimmune diseases has been reported.